Ease Digestive Symptoms of MS
Multiple sclerosis (MS) is most commonly associated with numbness, muscle spasms, mobility problems, and pain.
However, about two-thirds of MS patients ALSO regularly battle gastrointestinal symptoms.
The most common include nausea, heartburn, diarrhea, constipation, and dysphagia (trouble swallowing).
Instead of piling yet another prescription drug on top of all the others you’re taking, consider trying this natural digestion solution that’s had impressive results in people with MS.
Ginger is ALREADY known for its ability to ease nausea and other gastrointestinal issues.
But to find out if this natural solution could help folks with MS specifically, researchers gave volunteers with relapsing-remitting MS either ginger (500 mg) or a placebo three times daily with meals for 12 weeks.
The researchers used scores from the Visual Analog Scale, a symptom scale ranging from 0 to 100 (100 being the most severe), to determine the herb’s effectiveness against the participant’s digestive complaints.
The score for constipation frequency increased by 14 points in the placebo group but decreased by 23 points in the ginger group.
Constipation severity increased by 11 points in the placebo group but decreased by 24 points in the ginger group.
Ginger also reduced the frequency and severity of nausea, bloating, and abdominal pain.
In those taking the placebo, gastrointestinal symptoms worsened and became more frequent during the study period.
My preference is to use food rather than supplements whenever possible. But if you’re experiencing significant gastrointestinal symptoms—especially as a side effect of MS—then taking the higher dose ginger supplements will likely give you the best results.
This study used 1,500 mg daily. And up to 4,000 mg per day is generally considered safe.
P.S. Vitamin deficiency linked to multiple sclerosis?!
SOURCE:
“The effect of ginger consumption on serum levels of neurofilament light polypeptide, matrix metalloproteinase-9, interleukin-17, nitric oxide metabolites, and differential leukocyte count and score of disability status, quality of life, and gastrointestinal symptoms in patients with multiple sclerosis: a double-blind randomized controlled clinical trial,” IRCT registration number: IRCT20180818040827N3, Registration date: 2021-10-06, 1400/07/14
